StockNews.com started coverage on shares of Safeguard Scientifics (NYSE:SFE – Get Rating) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on the asset manager’s stock.
Safeguard Scientifics stock opened at $4.28 on Friday. The firm has a 50-day moving average price of $4.46 and a two-hundred day moving average price of $5.88. The firm has a market capitalization of $71.16 million, a price-to-earnings ratio of -85.60 and a beta of 1.05. Safeguard Scientifics has a 52-week low of $3.32 and a 52-week high of $8.98.
Safeguard Scientifics (NYSE:SFE – Get Rating) last issued its quarterly earnings results on Thursday, May 5th. The asset manager reported ($0.40) earnings per share for the quarter.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Madison Avenue Partners LP raised its holdings in Safeguard Scientifics by 48.7% during the 3rd quarter. Madison Avenue Partners LP now owns 965,242 shares of the asset manager’s stock worth $8,571,000 after buying an additional 316,209 shares during the period. Levin Capital Strategies L.P. acquired a new position in Safeguard Scientifics during the fourth quarter worth $1,306,000. Yakira Capital Management Inc. increased its holdings in Safeguard Scientifics by 8.1% during the first quarter. Yakira Capital Management Inc. now owns 1,092,108 shares of the asset manager’s stock worth $5,701,000 after buying an additional 82,158 shares during the last quarter. Two Sigma Advisers LP increased its holdings in Safeguard Scientifics by 151.4% during the third quarter. Two Sigma Advisers LP now owns 118,733 shares of the asset manager’s stock worth $1,054,000 after buying an additional 71,500 shares during the last quarter. Finally, Clayton Partners LLC increased its holdings in Safeguard Scientifics by 21.3% during the first quarter. Clayton Partners LLC now owns 297,066 shares of the asset manager’s stock worth $1,551,000 after buying an additional 52,172 shares during the last quarter. 60.59% of the stock is currently owned by institutional investors.
About Safeguard Scientifics (Get Rating)
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Further Reading
- Get a free copy of the StockNews.com research report on Safeguard Scientifics (SFE)
- These Are the Three (3) Most Upgraded Stocks For Q2
- MarketBeat: Week in Review 5/23 – 5/27
- Short Sellers Provide Entry Into Hibbet, Inc At Rock Bottom Prices
- Affirm Stock Has Affirmed a Bottom
- Airbnb: Bold Competitive Threats & A New World of Travel
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.